We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$58.8B
AUM Growth
+$7.51B
Cap. Flow
+$1.9B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.73%
Holding
979
New
37
Increased
681
Reduced
201
Closed
28

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$154M
2
SPOT icon
Spotify
SPOT
+$132M
3
NVDA icon
NVIDIA
NVDA
+$124M
4
MSFT icon
Microsoft
MSFT
+$107M
5
META icon
Meta Platforms (Facebook)
META
+$71.3M

Sector Composition

Rank Sector Weight
1 Technology 32.3%
2 Healthcare 12.75%
3 Consumer Discretionary 11.56%
4 Financials 10.82%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVRG icon
701
Evergy
EVRG
$20.1B
$5.1M 0.01%
74,012
+27,292
+58% +$1.83M
VIR icon
702
Vir Biotechnology
VIR
$1.47B
$5.07M 0.01%
1,006,891
+313,699
+45% +$1.68M
RAL
703
Ralliant Corp
RAL
$7.77B
$5.04M 0.01%
+103,984
New +$5.12M
NVR icon
704
NVR
NVR
$17.2B
$5.03M 0.01%
681
+49
+8% +$351K
BEN icon
705
Franklin Resources
BEN
$16.9B
$5.03M 0.01%
210,744
+2,652
+1% +$54.7K
TECH icon
706
Bio-Techne
TECH
$11.2B
$5M 0.01%
97,128
+2,736
+3% +$137K
EMN icon
707
Eastman Chemical
EMN
$7.8B
$4.96M 0.01%
66,460
+658
+1% +$51.7K
VCYT icon
708
Veracyte
VCYT
$4.52B
$4.92M 0.01%
+181,923
New +$5.27M
CPB icon
709
Campbell Soup
CPB
$6.51B
$4.81M 0.01%
157,745
+14,925
+10% +$525K
AMLX icon
710
Amylyx Pharmaceuticals
AMLX
$2.05B
$4.73M 0.01%
738,657
-1,691,701
-70% -$8.23M
HR icon
711
Healthcare Realty
HR
$7.42B
$4.69M 0.01%
295,659
+6,067
+2% +$92.3K
DYN icon
712
Dyne Therapeutics
DYN
$4.04B
$4.61M 0.01%
483,963
+169,377
+54% +$1.86M
MANH icon
713
Manhattan Associates
MANH
$8.97B
$4.54M 0.01%
23,182
+1,366
+6% +$248K
AMH icon
714
American Homes 4 Rent
AMH
$12B
$4.53M 0.01%
125,602
+12,579
+11% +$465K
TME icon
715
Tencent Music
TME
$14.5B
$4.44M 0.01%
227,607
+48,271
+27% +$759K
FCNCA icon
716
First Citizens BancShares
FCNCA
$24.6B
$4.44M 0.01%
2,267
+297
+15% +$539K
XNCR icon
717
Xencor
XNCR
$1.44B
$4.39M 0.01%
558,810
+181,698
+48% +$1.63M
OC icon
718
Owens Corning
OC
$11.5B
$4.38M 0.01%
31,860
+11,479
+56% +$1.59M
ARDX icon
719
Ardelyx
ARDX
$1.24B
$4.36M 0.01%
1,112,476
+260,757
+31% +$1.08M
HEI.A icon
720
HEICO Corp Class A
HEI.A
$35.4B
$4.28M 0.01%
16,544
+2,530
+18% +$554K
RYTM icon
721
Rhythm Pharmaceuticals
RYTM
$7B
$4.28M 0.01%
67,657
-40,472
-37% -$2.48M
PECO icon
722
Phillips Edison & Co
PECO
$5.48B
$4.26M 0.01%
121,594
+4,220
+4% +$149K
NXT icon
723
Nextpower Inc
NXT
$15.2B
$4.23M 0.01%
77,748
-12,462
-14% -$625K
FRT icon
724
Federal Realty Investment Trust
FRT
$10.9B
$4.19M 0.01%
44,129
+4,412
+11% +$417K
CUBE icon
725
CubeSmart
CUBE
$9.53B
$4.12M 0.01%
96,840
+22,300
+30% +$925K

Similar funds

Aberdeen Group's Q2 2025 Portfolio in Review

As of Q2 2025, Aberdeen Group held 979 positions worth $58.8B, up 15% from $51.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aberdeen Group deployed $1.9B of net new capital in Q2 2025, opening 37 new positions and adding to 681 existing holdings. Its largest new stake was On Holding: 756,875 shares worth $39.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Southern Copper, an estimated $61.4M trimmed.

  • Aberdeen Group's largest Q2 2025 buy was On Holding: 756,875 shares worth $39.4M.
  • Aberdeen Group added most to Apple in Q2 2025, an estimated $154M increase.
  • Aberdeen Group's biggest Q2 2025 reduction was Southern Copper, cutting an estimated $61.4M.
  • Aberdeen Group fully exited Globant in Q2 2025, selling an estimated $60.5M.
  • Aberdeen Group's ten largest holdings make up 35% of its $58.8B portfolio in Q2 2025.
  • Aberdeen Group opened 37 new positions and closed 28 in Q2 2025.
  • Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $58.8B.

Based on Aberdeen Group's 13F filing for Q2 2025, filed 24 Jul 2025.